Fundraising Overview - The company raised a total of RMB 417,999,977.28 through a non-public stock issuance, with a net amount of RMB 404,190,783.17 after deducting issuance costs [1] - The funds have been stored in a dedicated account, and a tripartite supervision agreement has been signed with the sponsor and the bank [1] Project Adjustment Details - The company plans to adjust the "Changchun Fresh Beer City Brewery Project" in terms of location, content, investment scale, and internal investment structure [3] - The project will change from a rental factory to a self-built factory, with an increased annual production capacity from 0.5 million tons to 1 million tons [3][4] - The total investment for the project will increase from RMB 7,851.28 million to RMB 15,577.90 million, while the amount of fundraising remains at RMB 5,004.47 million [3] Market and Company Development - The project aims to meet the growing market demand for craft beer in Changchun, which is expected to benefit from economic growth and increased consumer spending [5][6] - The company has established itself as a leading provider of brewing equipment and aims to enhance the quality of domestic beer production [6][7] - The craft beer market in China is projected to grow significantly, with a compound annual growth rate of 17% expected until 2025 [8] Approval and Compliance - The project has received the necessary approvals and has completed the required registration work for the new implementation site [8] - The adjustments have been reviewed and approved by the company's board of directors and supervisory board, ensuring compliance with relevant regulations [9][10]

| 债券代码：243279 | 债券简称：25 | 国金 | | | --- | --- | --- | --- | | | | 04 | | | | | | 公告编号：临 | | 证券代码：600109 | 证券简称：国金证券 | | 2025－62 | 国金证券股份有限公司 2025年面向专业投资者公开发行公司债券（第四期） 发行结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载，误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据中国证券监督管理委员会《关于同意国金证券股份有限公司 向专业投资者公开发行公司债券注册的批复》（证监许可[2024]77 号），国金证券股份有限公司（以下简称"公司"）获准向专业投资 者公开发行公司债券面值总额不超过150亿元，批复有效期自同意注 册之日起24个月内有效，公司在注册有效期内可以分期发行公司债券。 二〇二五年七月十七日 根据《国金证券股份有限公司2025年面向专业投资者公开发行公 司债券（第四期）发行公告》，公司2025年面向专业投资者公开发行 公司债券（第四期）（以下简称"本期债券"）发行规模不超过15 亿元，发行 ...

Core Points - China Securities Depository and Clearing Corporation has issued an urgent document requiring brokerages to report the signing status of risk disclosure statements for the Sci-Tech Innovation Board's growth tier [1] - The notice aims to implement the guidelines for enhancing the adaptability of the Sci-Tech Innovation Board and its growth tier, supporting appropriate investor management [1] - Starting from September 22, 2025, brokerages must categorize accounts of ordinary investors who have signed the risk disclosure as type C, while those who have not signed will be categorized as type K [1] - Existing investors' accounts will be uniformly categorized as type K after the end of trading on September 19, 2025 [1] Regulatory Framework - The Shanghai Stock Exchange has established mandatory clauses for the risk disclosure statement for stocks in the growth tier, effective from July 13 [2] - Brokerages are required to inform ordinary investors of the risks associated with new registered growth tier stocks before they can participate in trading [2] - Investors must sign the risk disclosure statement in paper or electronic form; brokerages cannot accept orders from those who have not signed [2] Investor Education - Brokerages are expected to provide comprehensive risk warnings and investor education through various channels, including SMS, phone calls, and trading software notifications [2] - Several brokerages have already integrated features in their apps to facilitate the opening of trading permissions for the growth tier, allowing investors to sign the risk disclosure statement online [2] - Investment advisors are actively reminding clients with Sci-Tech Innovation Board permissions to sign new agreements to trade growth tier stocks [2]

公司首次公开发行股票募集资金净额用于以下募投项目： 单位：万元 注 国金证券股份有限公司 关于厦门特宝生物工程股份有限公司 使用自有资金支付募投项目所需资金并以募集资金等额 置换的核查意见 国金证券股份有限公司（以下简称"保荐机构"）作为厦门特宝生物工程股份 有限公司（以下简称"公司"或"特宝生物"）首次公开发行股票并在科创板上市 的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股 票上市规则》《上海证券交易所科创板上市公司自律监管指引第1号——规范运作》 等相关规定，对特宝生物使用自有资金支付募投项目所需资金并以募集资金等额置 换的事项进行了核查，核查情况及核查意见如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意厦门特宝生物工程股份有限公司首次 公开发行股票注册的批复》（证监许可〔2019〕2828 号）核准，并经上海证券交易 所"自律监管决定书〔2020〕21 号"批准，公司向社会首次公开发行人民币普通股 （A 股）4,650 万股，每股发行价为 8.24 元，本次募集资金总额为人民币 38,316.00 万元，根据有关规定扣除发行费用 5,271.37 万元后，实 ...

Core Viewpoint - The integration of AI technology into the securities industry is transforming traditional investment advisory services, enabling firms to offer personalized, efficient, and comprehensive investment solutions to clients [1][2]. Group 1: AI Integration in Securities Firms - Over the past year, more than ten securities firms, including Guosen Securities, GF Securities, and China Galaxy, have launched AI investment advisors, AI digital humans, or AI voice assistants, covering the entire investment lifecycle from pre-investment strategies to post-investment support [1][2]. - AI assistants are enhancing various functions such as customer service, research analysis, compliance management, and marketing, becoming essential tools in the digital transformation of securities firms [2][4]. Group 2: Specific AI Applications - Guosen Securities' "Xin Investment Advisor AI Assistant" supports over 3,000 investment advisors by automating tasks like individual stock diagnosis and compliance documentation, significantly improving service efficiency [2]. - GF Securities' "Yitaojin App" introduced an AI voice command feature, allowing clients to perform stock queries and transactions through voice, enhancing user experience [2]. - China Galaxy Securities is focusing on deepening buy-side services and enhancing its self-developed advisory platform "G-Winstar" to improve marketing service systems [3]. Group 3: Technology and User Experience - Many securities firms are utilizing large models like DeepSeek and Qianwen, integrating them with proprietary strategies and data to provide personalized services across various platforms [4][5]. - The AI assistants are designed to support multiple interaction formats, including text, voice, charts, and market data, emphasizing personalized service based on client trading behavior [4][5]. - The competition among securities firms has shifted from merely having AI capabilities to the effectiveness and usability of these tools, with a focus on understanding regulations and client needs [5].

Core Viewpoint - The performance forecasts for the first half of 2025 from multiple listed securities firms indicate a significant increase in net profits, with many firms reporting growth rates exceeding 100% year-on-year, driven by improved market conditions and enhanced wealth management and investment returns [1][3][7]. Group 1: Performance Forecasts - A total of 27 listed securities firms or their subsidiaries released mid-year forecasts, with 14 firms expecting net profit growth exceeding 100% [1]. - Notable firms include Huaxi Securities, expecting a net profit of 445 million to 575 million yuan, representing a year-on-year increase of 1,025.19% to 1,353.90% [2]. - Guolian Minsheng is projected to achieve a net profit of 1.129 billion yuan, reflecting a growth of 1,183.00% [2]. Group 2: Drivers of Growth - The increase in profits is attributed to a rise in capital market activity, leading to substantial growth in wealth management and securities investment returns [3]. - Guotai Junan reported a projected net profit of 1.092 billion to 1.137 billion yuan, indicating a year-on-year increase of 140% to 150% due to enhanced wealth management and self-investment performance [3]. - Huayin Securities noted a significant increase in wealth management revenue and fair value changes in equity investments, forecasting a net profit of 270 million to 350 million yuan, up 118.98% to 183.86% [3]. Group 3: Sector Outlook - The overall operating environment for the securities industry is improving, with expectations for continued strong growth in mid-year performance [7][8]. - Analysts suggest that the securities sector is entering a new phase of high-quality development, with a focus on differentiated competition and refined management practices [8]. - Recommendations include monitoring mergers and acquisitions, wealth management transformations, and innovative business licenses as key investment themes [8][9].

证券代码：600109 证券简称：国金证券 公告编号：临 2025－61 债券代码：115630 债券简称：23 国金 06 国金证券股份有限公司 国金证券股份有限公司 董事会 二〇二五年七月十五日 国金证券股份有限公司（以下简称"本公司"）于 2023 年 7 月 14 日发行了国金证券股份有限公司 2023 年面向专业投资者公开发行 公司债券(第五期)（债券简称：23 国金 06，债券代码：115630）, 发行总额为人民币 10 亿元，票面利率为 2.98%，发行期限为 3 年。 详 见 公 司 于 2025 年 7 月 7 日 登 载 于 上 海 证 券 交 易 所 网 站 （http://www.sse.com.cn）的《国金证券股份有限公司 2023 年面向 专业投资者公开发行公司债券(第五期)2025 年付息公告》。 2025 年 7 月 14 日，本公司"23 国金 06"公司债券付息完成， 付息总额为人民币 29,800,000.00 元。 特此公告。 关于"23 国金 06"公司债券付息完成的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容 ...

管规则适用指引——上市类第 1 号》《深圳证券交易所上市公司自律监管指引第 相关股票异常交易监管》等法律法规的规定，对本次交易相关内幕信息知情人买 卖股票情况的自查报告进行了核查，具体如下： 一、本次交易的内幕信息知情人自查期间 本次交易相关内幕信息知情人买卖上市公司股票情况的自查期间为自《思创 医惠科技股份有限公司重大资产出售暨关联交易报告书（草案）》 国金证券股份有限公司 关于思创医惠科技股份有限公司本次交易相关主体买卖股 票情况的自查报告的核查意见 思创医惠科技股份有限公司（以下简称"上市公司"）拟向苍南县山海数字 科技有限公司出售上市公司持有的医惠科技有限公司（以下简称"医惠科技"或 "标的公司"）100%股权，根据《上市公司重大资产重组管理办法》规定，上述 交易事项构成重大资产重组（以下简称"本次交易"）。 国金证券股份有限公司（以下简称"国金证券"或"本独立财务顾问"）担 任本次交易的独立财务顾问，根据《上市公司重大资产重组管理办法》《公开发 行证券的公司信息披露内容与格式准则第 26 号——上市公司重大资产重组》 《监 （以下简称"《重 组报告书》"）公告前 6 个月起至《重组报告书》披露前一日 ...

从业绩驱动因素来看，自营投资业务成为核心引擎。9 家券商中，有8家在公告中提及自营投资业务收入或相关内容，例 如，国信证券在报告中提到"自营投资业务收入及经纪业务手续费净收入等主要业务收入相比上年同期有较大幅度增长"， 国金证券也提及"报告期内财富管理业务、自营投资业务业绩同比增长"。 这一表现与上半年 A 股市场行情密切相关——今年上半年沪深两市日均成交量达1.35万亿元，较2024年同期放量近30%， 交投活跃度显著提升。受益于权益类资产价格普遍上涨，券商自营业务通过持仓增值、交易获利等方式实现收益增长，凸 显出其 "靠天吃饭"、与市场成交量高度关联的特点。 A股中报行情陆续展开，首批9家券商率先交出上半年"成绩单"，业绩集体报喜。其中，国信证券以47.8亿元至55.3亿元的 预计归母净利润领跑，同比增幅达52%至76%；国联民生和华西证券的预计归母净利润同比增幅更是超1000%，国金证券、 华林证券等多家券商的同比增幅也均超100%，展现出强劲的增长态势。 | | | 部分上市券商2025年半年度业绩预告 | | | | --- | --- | --- | --- | --- | | 券商简称 | | ...

Core Viewpoint - The article discusses the new requirements for investors wishing to participate in the subscription and trading of newly registered stocks in the Sci-Tech Innovation Board's growth tier, emphasizing the necessity of signing a risk disclosure agreement. Group 1: Trading Permissions and Requirements - Several brokerage apps, including Guojin Securities, now support online activation of trading permissions for the Sci-Tech Innovation Board's growth tier, requiring investors to sign a risk disclosure agreement [2] - The threshold for opening trading permissions in the growth tier remains consistent with the Sci-Tech Innovation Board, requiring an asset of 500,000 and two years of investment experience [7] - Investors must sign the "Sci-Tech Innovation Board Stock Investor Risk Disclosure Agreement" to open trading permissions, and an additional "Growth Tier Risk Disclosure Agreement" is required for participating in new registered stocks [7][10] Group 2: Regulatory Developments - The China Securities Regulatory Commission has accepted the IPO registration application of Heyuan Bio, which is expected to be the first stock in the newly registered growth tier [9] - The Shanghai Stock Exchange issued the "Mandatory Clauses for the Risk Disclosure Agreement for Stocks of Sci-Tech Innovation Board Growth Tier Enterprises" on July 13, requiring brokerages to inform investors of risks before they can participate in new stock subscriptions [10] - Existing investors trading stocks that were listed before this notice and have not yet achieved profitability do not need to sign the new risk disclosure agreement [11] Group 3: Investor Education and Risk Management - The exchange emphasizes the importance of comprehensive risk education for investors, urging brokerages to utilize multiple channels to inform investors about the risks associated with trading in the growth tier [11][12] - Brokerages are expected to coordinate and prepare their technical systems to facilitate the signing of the risk disclosure agreements in an orderly manner [12]